Kintegral Advisory’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10.7M | Hold |
29,489
| – | – | 0.87% | 30 |
|
|
2026
Q1 | $10.4M | Sell |
29,489
-1,308
| -4% | -$466K | 0.98% | 21 |
|
|
2025
Q4 | $10.1M | Sell |
30,797
-842
| -3% | -$267K | 0.85% | 23 |
|
|
2025
Q3 | $8.93M | Sell |
31,639
-142
| -0.4% | -$41.2K | 0.76% | 24 |
|
|
2025
Q2 | $8.87M | Sell |
31,781
-48
| -0.2% | -$13.6K | 0.81% | 26 |
|
|
2025
Q1 | $9.92M | Sell |
31,829
-106
| -0.3% | -$31.3K | 1% | 20 |
|
|
2024
Q4 | $8.32M | Sell |
31,935
-1,488
| -4% | -$441K | 0.79% | 24 |
|
|
2024
Q3 | $10.8M | Sell |
33,423
-438
| -1% | -$143K | 0.99% | 19 |
|
|
2024
Q2 | $10.6M | Buy |
33,861
+3,917
| +13% | +$1.15M | 1.01% | 15 |
|
|
2024
Q1 | $8.51M | Sell |
29,944
-93
| -0.3% | -$27.2K | 0.85% | 24 |
|
|
2023
Q4 | $8.65M | Sell |
30,037
-191
| -0.6% | -$52K | 0.96% | 19 |
|
|
2023
Q3 | $8.12M | Sell |
30,228
-18
| -0.1% | -$4.49K | 1% | 18 |
|
|
2023
Q2 | $6.72M | Hold |
30,246
| – | – | 0.8% | 28 |
|
|
2023
Q1 | $7.31M | Sell |
30,246
-1,625
| -5% | -$399K | 0.94% | 21 |
|
|
2022
Q4 | $8.37M | Buy |
31,871
+8,791
| +38% | +$2.36M | 1.11% | 16 |
|
|
2022
Q3 | $5.2M | Hold |
23,080
| – | – | 0.72% | 27 |
|
|
2022
Q2 | $5.62M | Buy |
23,080
+489
| +2% | +$120K | 0.73% | 29 |
|
|
2022
Q1 | $5.46M | Buy |
22,591
+505
| +2% | +$116K | 0.6% | 35 |
|
|
2021
Q4 | $4.97M | Hold |
22,086
| – | – | 0.51% | 46 |
|
|
2021
Q3 | $4.7M | Hold |
22,086
| – | – | 0.55% | 40 |
|
|
2021
Q2 | $5.38M | Hold |
22,086
| – | – | 0.64% | 34 |
|
|
2021
Q1 | $5.5M | Hold |
22,086
| – | – | 0.71% | 32 |
|
|
2020
Q4 | $5.08M | Hold |
22,086
| – | – | 0.69% | 31 |
|
|
2020
Q3 | $5.61M | Sell |
22,086
-711
| -3% | -$176K | 0.85% | 26 |
|
|
2020
Q2 | $5.38M | Hold |
22,797
| – | – | 0.86% | 26 |
|
|
2020
Q1 | $4.62M | Buy |
22,797
+2,550
| +13% | +$557K | 0.9% | 24 |
|
|
2019
Q4 | $4.88M | Hold |
20,247
| – | – | 0.89% | 20 |
|
|
2019
Q3 | $3.92M | Hold |
20,247
| – | – | 0.78% | 29 |
|
|
2019
Q2 | $3.73M | Hold |
20,247
| – | – | 0.76% | 31 |
|
|
2019
Q1 | $3.85M | Buy |
20,247
+1,636
| +9% | +$312K | 0.81% | 26 |
|
|
2018
Q4 | $3.62M | Buy |
+18,611
| New | +$3.63M | 1.07% | 22 |
|
Other funds holding AMGN
Kintegral Advisory's AMGN Position: Q2 2026 in Review
Kintegral Advisory held its Amgen (AMGN) position steady in Q2 2026 at 29,489 shares worth $10.7M. The position accounts for 0.87% of the portfolio, ranked #30.
Kintegral Advisory first reported a position in AMGN in Q4 2018 and has held it in 31 quarters since. The position peaked at $10.8M in Q3 2024. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Kintegral Advisory held 29,489 shares of Amgen worth $10.7M as of Q2 2026.
- Kintegral Advisory left its Amgen share count unchanged in Q2 2026.
- Amgen made up 0.87% of Kintegral Advisory's portfolio in Q2 2026, its #30 holding.
- Kintegral Advisory first reported a position in Amgen in Q4 2018 and has held it in 31 quarters since.
- Kintegral Advisory's Amgen position peaked at $10.8M in Q3 2024.
- 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Kintegral Advisory's 13F filing for Q2 2026, filed 29 Jul 2026.